Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

Published September 30, 2026 · Category: Finance

Overview

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.

Source

Originally published at www.cnbc.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.